Breast Cancer Study Boosts Avastin (AP)


AP - Biotech company Genentech Inc. and Swiss drug maker Roche Holding AG said Friday that an interim analysis of clinical trial data showed that cancer treatment Avastin met its primary endpoint of increasing survival rates in breast cancer patients.

Read more...